Mercia Pharma Inc.

 



Mercia Pharma Inc., has established a portfolio of unique products to prevent and treat diseases which afflict millions of people worldwide.  Based on its clinically proven immunotherapeutic technology, MERIT, the Company has therapeutic and prophylactic vaccines in development for three broad disease categories:

  • Autoimmune disease
  • Chronic disease
  • Infectious disease


MERIT promises to deliver novel and effective therapies addressing the unmet medical needs of a number of serious medical conditions.